237 related articles for article (PubMed ID: 26125105)
1. Malignancies in systemic lupus erythematosus: a 2015 update.
Goobie GC; Bernatsky S; Ramsey-Goldman R; Clarke AE
Curr Opin Rheumatol; 2015 Sep; 27(5):454-60. PubMed ID: 26125105
[TBL] [Abstract][Full Text] [Related]
2. Malignancies in systemic lupus erythematosus: an update.
Ladouceur A; Clarke AE; Ramsey-Goldman R; Bernatsky S
Curr Opin Rheumatol; 2019 Nov; 31(6):678-681. PubMed ID: 31403485
[TBL] [Abstract][Full Text] [Related]
3. Systemic lupus and malignancies.
Bernatsky S; Kale M; Ramsey-Goldman R; Gordon C; Clarke AE
Curr Opin Rheumatol; 2012 Mar; 24(2):177-81. PubMed ID: 22227880
[TBL] [Abstract][Full Text] [Related]
4. Malignancy in systemic lupus erythematosus: what have we learned?
Bernatsky S; Ramsey-Goldman R; Clarke AE
Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):539-47. PubMed ID: 19591783
[TBL] [Abstract][Full Text] [Related]
5. Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis.
Clarke AE; Pooley N; Marjenberg Z; Langham J; Nicholson L; Langham S; Embleton N; Wang X; Desta B; Barut V; Hammond ER
Semin Arthritis Rheum; 2021 Dec; 51(6):1230-1241. PubMed ID: 34710720
[TBL] [Abstract][Full Text] [Related]
6. Systemic lupus erythematous and malignancy risk: a meta-analysis.
Cao L; Tong H; Xu G; Liu P; Meng H; Wang J; Zhao X; Tang Y; Jin J
PLoS One; 2015; 10(4):e0122964. PubMed ID: 25885411
[TBL] [Abstract][Full Text] [Related]
7. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
Dreyer L; Faurschou M; Mogensen M; Jacobsen S
Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
[TBL] [Abstract][Full Text] [Related]
8. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
Sultan SM; Ioannou Y; Isenberg DA
Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
[TBL] [Abstract][Full Text] [Related]
9. A review on SLE and malignancy.
Choi MY; Flood K; Bernatsky S; Ramsey-Goldman R; Clarke AE
Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):373-396. PubMed ID: 29224679
[TBL] [Abstract][Full Text] [Related]
10. Systemic lupus erythematosus and lymphoma: Incidence, pathogenesis and biology.
Klein A; Polliack A; Gafter-Gvili A
Leuk Res; 2018 Dec; 75():45-49. PubMed ID: 30458319
[TBL] [Abstract][Full Text] [Related]
11. An international cohort study of cancer in systemic lupus erythematosus.
Bernatsky S; Boivin JF; Joseph L; Rajan R; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Petri M; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Isenberg D; Rahman A; Aranow C; Dooley MA; Steinsson K; Nived O; Sturfelt G; Alarcón G; Senécal JL; Zummer M; Hanly J; Ensworth S; Pope J; El-Gabalawy H; McCarthy T; St Pierre Y; Ramsey-Goldman R; Clarke A
Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
[TBL] [Abstract][Full Text] [Related]
12. Managing cancer risk in patients with systemic lupus erythematous.
Ladouceur A; Bernatsky S; Ramsey-Goldman R; Clarke AE
Expert Rev Clin Immunol; 2018 Oct; 14(10):793-802. PubMed ID: 30183456
[TBL] [Abstract][Full Text] [Related]
13. Factors mediating cancer risk in systemic lupus erythematosus.
Hardenbergh D; Molina E; Naik R; Geetha D; Chaturvedi S; Timlin H
Lupus; 2022 Oct; 31(11):1285-1295. PubMed ID: 36059254
[TBL] [Abstract][Full Text] [Related]
14. Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study.
Azrielant S; Tiosano S; Watad A; Mahroum N; Whitby A; Comaneshter D; Cohen AD; Amital H
Immunol Res; 2017 Apr; 65(2):464-469. PubMed ID: 28091805
[TBL] [Abstract][Full Text] [Related]
15. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus.
Mellemkjaer L; Andersen V; Linet MS; Gridley G; Hoover R; Olsen JH
Arthritis Rheum; 1997 Apr; 40(4):761-8. PubMed ID: 9125261
[TBL] [Abstract][Full Text] [Related]
16. Systemic lupus erythematosus and malignancies: a review article.
Tessier-Cloutier B; Clarke AE; Ramsey-Goldman R; Gordon C; Hansen JE; Bernatsky S
Rheum Dis Clin North Am; 2014 Aug; 40(3):497-506, viii. PubMed ID: 25034158
[TBL] [Abstract][Full Text] [Related]
17. The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis.
Song L; Wang Y; Zhang J; Song N; Xu X; Lu Y
Arthritis Res Ther; 2018 Dec; 20(1):270. PubMed ID: 30522515
[TBL] [Abstract][Full Text] [Related]
18. Hodgkin's lymphoma in systemic lupus erythematosus.
Bernatsky S; Ramsey-Goldman R; Isenberg D; Rahman A; Dooley MA; Sibley J; Boivin JF; Joseph L; Armitage J; Zoma A; Clarke A
Rheumatology (Oxford); 2007 May; 46(5):830-2. PubMed ID: 17255135
[TBL] [Abstract][Full Text] [Related]
19. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus.
Ragnarsson O; Gröndal G; Steinsson K
Lupus; 2003; 12(9):687-91. PubMed ID: 14514131
[TBL] [Abstract][Full Text] [Related]
20. The Cancer Risk Profile of Systemic Lupus Erythematosus Patients.
Hardenbergh D; Naik R; Manno R; Azar A; Monroy Trujillo JM; Adler B; Haque U; Timlin H
J Clin Rheumatol; 2022 Jan; 28(1):e257-e262. PubMed ID: 33657590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
